Ken Reali is a seasoned executive with over three decades of experience in the medical device industry. He served as the CEO of Bioventus from April 2020 to 2023 and played a significant role in the company's growth and innovation. Before joining Bioventus, Reali was the President and CEO of Clinical Innovations from June 2015 to early 2020, where he led the company towards a successful sale. His career is marked by considerable expertise in various areas, including product development, global marketing, business development, commercialization, sales of medical devices, and ethics and compliance.
Reali's leadership skills extend beyond his roles as CEO. He has worked with medical societies, patient advocacy groups, governmental agencies, and both public and private insurance companies. His experience encompasses investor relations, capital funding, strategic planning, acquisitions, quality and lean production, and operations. His career journey began at Biomet and spanned significant roles at Stryker, Smith & Nephew, and Baxano Surgical. Furthermore, he has contributed to the broader industry as a board member of AdvaMed and Dysis Medical, a women's healthcare company, and as Chairman of the Ethics and Compliance Committee for AdvaMed.
Driving innovation for treating correctable and preventable conditions in the newborn care market